Novan Therapeutics landed $78 million from the U.S. Biomedical Advanced Research and Development Authority to further develop the North Carolina-based company's technology that delivers nitric oxide gas to thermal wounds.
Ferring Pharmaceuticals bolstered its controlled-release, labor-induction delivery platform with Phase III data as the company awaits its approval from both European and U.S. authorities.
Researchers at the Institute of Plastics Processing (IKV) at RWTH Aachen University in Germany are developing a controlled-release foam that can deliver drugs to treat diseases such as overactive bladder.
French drug delivery company Flamel Technologies ($FLML) is snatching up St. Louis-based Éclat Pharmaceuticals to access its specialty pharmaceutical and regulatory muscle for a planned expansion in the U.S. and elsewhere.
Columbia Laboratories is cutting 42% of its workforce and moving ahead with plans to advance a vaginal progesterone gel, despite FDA's rejection of the product.
Israeli pharmaceutical company Sol-Gel Technologies says it nailed down a $27 million development and licensing deal with an as-yet unnamed U.S. pharmaceutical company regarding a "major"...
MicroCHIPS heavily promoted some long-awaited good news this week about its wireless, implantable drug delivery microchip. A small human trial proved that it can work in people, and the patients were...
Titan Pharmaceuticals ($TTNP) now envisions an NDA submission to the FDA for its implantable, controlled release treatment for opioid dependence during its fiscal 2012 third quarter. The South San...
Say hello to Bydureon, a once-weekly injectable treatment for Type 2 diabetes finally approved by the FDA on Jan. 27. Amylin Pharmaceuticals ($AMLN) developed the drug using controlled release drug
For the second time this year, Durect ($DRRX) faces a setback over its controlled-release anti-pain drug Posidur. The Cupertino, CA-based company disclosed that its European development and marketing